Sen. James M. Inhofe bought Intrexon Corporation (XON)
Sen. James M. Inhofe (R-OK) · $15K–$50K · traded Feb 16, 2017
- Transaction
- Bought
- Amount
- $15K–$50K
- Owner
- The member
- Traded
- Feb 16, 2017
- Disclosed
- Mar 2, 2017
- Days to disclose
- 14
- Asset type
- Stock
- As filed
- Intrexon Corporation
Other trades in this filing
- Mar 2, 2017$15K–$50K
Sold (partial) Bristol-Myers Squibb Company BMY
$15K–$50K · Traded Feb 28, 2017 · disclosed Mar 2, 2017
- Mar 2, 2017$50K–$100K
Sold (partial) Allergan plc AGN
$50K–$100K · Traded Feb 14, 2017 · disclosed Mar 2, 2017
- Mar 2, 2017$50K–$100K
$50K–$100K · Traded Feb 10, 2017 · disclosed Mar 2, 2017
- Mar 2, 2017$15K–$50K
Bought Bristol-Myers Squibb Company BMY
$15K–$50K · Traded Feb 1, 2017 · disclosed Mar 2, 2017
- Mar 2, 2017$50K–$100K
Sold (partial) Synchrony Financial SYF
$50K–$100K · Traded Feb 1, 2017 · disclosed Mar 2, 2017
Recent Congress trades in XON
- Dec 13, 2017$15K–$50K
Sen. James M. Inhofe (R-OK)
Sold (full) Intrexon Corporation XON
$15K–$50K · Traded Nov 10, 2017 · disclosed Dec 13, 2017
- Nov 14, 2017$1M–$5M
Sen. Mark R. Warner (D-VA)
Sold (partial) Intrexon Corporation XON
$1M–$5M · Traded Oct 18, 2017 · disclosed Nov 14, 2017
- Aug 25, 2017$1K–$15K
Sen. James M. Inhofe (R-OK)
Bought Intrexon Corporation XON
$1K–$15K · Traded Aug 23, 2017 · disclosed Aug 25, 2017
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.